Krafton IPO draws tepid response from institutions IPO estimated to be 250-300 times oversubscribed, lower than recent big deals
Translated by Kim So-in 공개 2021-07-30 08:10:01
이 기사는 2021년 07월 30일 08:07 thebell 에 표출된 기사입니다.
South Korean game developer Krafton’s initial public offering (IPO) drew mediocre demand from institutional investors in its recent bookbuilding process.The IPO of Krafton was estimated to be 250-300 times oversubscribed during its bookbuilding process completed on July 27, according to industry sources. The listing drew positive response from investors considering the second-largest ever deal size of 4.3 trillion won ($3.75 billion) based on the top end of the proposed IPO price range.
But the demand was weaker than other companies’ listings that were carried out earlier this year. In March, SK Bioscience’s listing worth 1.49 trillion won was oversubscribed by 1,275 times and the IPO of SK IE Technology (SKIET) worth 2.25 trillion won was oversubscribed by 1,882 times in May. This was the most competitive IPO ever.
Industry sources noted that the absence of small and medium-sized institutions was one of the reasons for the relatively low competition as institutions had to apply for a five times larger value for Krafton’s shares than other big deals.
Krafton has set a minimum of 1,000 shares to receive shares, which is on par with listing of SKIET and SK Bioscience. However, the value differs because the proposed price band is different for each deal.
The game developer has set the indicative range between 400,000 and 498,000 won. Based on the price range, each institution has to place bids worth 400 million-498 million won to receive shares, with the company likely to set the IPO price at 498,000 won.
This is 4.7 times larger than SKIET’s minimum bid amount of 105 million won and 7.6 times larger than SK Bioscience's 65 million won.
Industry sources said around 300 domestic institutional investors participated in the Krafton’s bookbuilding process, which is significantly less than SKIET's bookbuilding process, in which 1,220 institutions participated.
“Most of the small and medium-sized institutions that usually invested only 100 to 400 million won in one big deal gave up because they don’t have enough buying power,” said an official at an asset management firm.
The absence of small and mid-sized institutions is likely to make large domestic and foreign institutions with long-term perspectives obtain more shares.
Major investors including BlackRock and Singapore sovereign wealth fund GIC have sought to get their hands on Krafton’s shares. They also have agreed to lock-up agreement.
Underwriters plan to allocate more shares to large institutions in consideration of the stock price after listing. “Krafton plans to allocate more shares to overseas institutions, mainly to sovereign wealth funds and long funds, which have long-term perspectives, and to domestic institutions which have agreed to lock-up agreement,” an industry sources said.
This is likely to reduce Krafton’s concern about a stock overhang, which happens when a massive amount of shares are offloaded by shareholders who hold a large stake. (Reporting by Kyung-ju Lee)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
관련기사
best clicks
최신뉴스 in 전체기사
-
- DS이앤이, 스마트 팩토리 첫발… 증축 공사 준공
- 쌍용정보통신, 1분기 매출 679억·영업손실 31억 기록
- [HLB '리보세라닙' 미국 진출기]진양곤 회장 "할 도리 다 했다, 남은 건 하늘의 뜻"
- [HLB '리보세라닙' 미국 진출기]아바스틴 왕위 잇는 '간암 타깃' 올인, '병용'으로 길 열었다
- 젬백스링크, 포니에이아이로부터 300억 투자유치
- [HLB '리보세라닙' 미국 진출기]K-바이오 모두가 주목한다, 미국 FDA 허가 결정 'D-1'
- [우리투자증권의 부활]'격전지' IB 비즈니스, 우리은행이 '열쇠' 쥐고 있다
- 드림텍, 반도체 모듈 사업 진출…인도서 모듈 양산
- 티에스넥스젠, 뉴로소나 투자로 글로벌 뇌질환 시장 진출
- [Red & Blue]엑스페릭스 품 떠나는 엑스플러스, 신사업 기대감 퍼질까